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INTRODUCTION
Neonatal hypoxic-ischemic brain injury (HI) remains one of 
the most common causes of death and severe neurologic 
morbidity in infants and children, resulting in chronic cogni-
tive, motor, and sensory deficits.1,2 However, currently, there is 
no therapy to repair the HI except therapeutic hypothermia, 
which offers very limited functional recovery.3,4 Consequently, 
the development of supplementary or alternative therapies, that 
act synergistically with hypothermia or are effective when used 
alone, are needed to reduce the mortality and morbidity in 
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Purpose: To elucidate the brain’s intrinsic response to injury, we tracked the response of neural stem/progenitor cells (NSPCs) 
located in ventricular-subventricular zone (V-SVZ) to hypoxic-ischemic brain injury (HI). We also evaluated whether transduc-
tion of V-SVZ NSPCs with neurogenic factor NeuroD1 could enhance their neurogenesis in HI.
Materials and Methods: Unilateral HI was induced in ICR neonatal mice. To label proliferative V-SVZ NSPCs in response to HI, 
bromodeoxyuridine (BrdU) and retroviral particles encoding LacZ or NeuroD1/GFP were injected. The cellular responses of 
NSPCs were analyzed by immunohistochemistry.
Results: Unilateral HI increased the number of BrdU+ newly-born cells in the V-SVZ ipsilateral to the lesion while injury reduced 
the number of newly-born cells reaching the ipsilateral olfactory bulb, which is the programmed destination of migratory V-SVZ 
NSPCs in the intact brain. These newly-born cells were directed from this pathway towards the lesions. HI significantly increased the 
number of newly-born cells in the cortex and striatum by the altered migration of V-SVZ cells. Many of these newly-born cells differ-
entiated into active neurons and glia. LacZ-expressing V-SVZ NSPCs also showed extensive migration towards the non-neurogenic 
regions ipsilateral to the lesion, and expressed the neuronal marker NeuN. NeuroD1+/GFP+ V-SVZ NSPCs almost differentiated into 
neurons in the peri-infarct regions.
Conclusion: HI promotes the establishment of a substantial number of new neurons in non-neurogenic regions, suggesting in-
trinsic repair mechanisms of the brain, by controlling the behavior of endogenous NSPCs. The activation of NeuroD1 expression 
may improve the therapeutic potential of endogenous NSPCs by increasing their neuronal differentiation in HI.
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newborn infants with HI. 
It is conventionally accepted that neuronal generation does 
not take place beyond fetal life, and therefore, neuronal regen-
eration does not occur in the vast majority of the post-develop-
mental “non-neurogenic” central nervous system (CNS) after 
injury or disease.5 However, neurogenesis from neural stem/pro-
genitor cells (NSPCs) in two restricted neurogenic niches—ven-
tricular-subventricular zone (V-SVZ) near the lateral ventricles 
and hippocampal subgranular zone—of the mammalian CNS 
has great implications for the growing field of research on en-
dogenous NSPCs in the mature nervous system.6-16 Manipula-
tion of these actively dividing or relatively quiescent NSPCs 
could supply cell population with immense neuroregenerative 
potential. Stimulated endogenous NSPCs could be a source of 
new neurons or glial cells that replace lost neural cells in CNS 
diseases. Notably, the V-SVZ peaks in size during the first week 
of postnatal development in rodents and at approximately the 
35th week of gestation in humans as a result of extensive cell 
proliferation.17 The human neonatal V-SVZ has a remarkable 
neurogenic capacity,18,19 suggesting that NSPCs in V-SVZ may 
provide an endogenous cell population for neural regeneration 
after neonatal brain injury.
As a model for HI, we employed the Rice-Vannucci model20 
which has been most well-accepted as rendering one of the 
experimentally destructive injuries: permanently ligating uni-
lateral common carotid artery on postnatal day 7 (P7) followed 
by hypoxia (8–10% O2). This procedure results in extensive HI 
that severely damages the ipsilateral cerebral hemisphere, in-
cluding non-neurogenic regions such as the sensorimotor cor-
tex, subcortex, and striatum, while preserving the contralateral 
hemisphere as an intact control. We believed that such a model 
would support an ideal opportunity to estimate the response 
of endogenous NSPCs to a devastating, clinically-relevant se-
vere HI. 
In this study, we tracked the response of endogenous V-SVZ 
NSPCs to a severe clinically relevant neonatal HI to investigate 
the brain’s intrinsic repair mechanism to injury, by using ret-
roviral vectors transducing the LacZ reporter gene and by 
bromodeoxyuridine (BrdU) to label proliferative NSPCs. In 
addition, we also evaluated whether a retroviral transduction 
of V-SVZ NSPCs with neurogenic gene NeuroD1 could en-
hance their neurogenesis in HI, which may enhance therapeu-
tic potential of endogenous NSPCs in CNS disorders. 
MATERIALS AND METHODS
Induction of unilateral HI brain injury
Through a ventral midline neck incision, the right common 
carotid artery of anesthetized ICR (CD1) mice on postnatal 
day 7 (P7) was permanently ligated with the surgical suture 
silk. After the incision was closed, the animals were kept warm 
until awake and returned to their dams for 3 h. The pups were 
then placed in an acrylic chamber with hypoxic atmosphere 
of 92% N2 and 8% O2 for 2.2 h. The animals’ body temperature 
was maintained at 37°C. 
BrdU labeling and detection
Two hours after the induction of unilateral HI, the mice were 
intraperitoneally administered 50 mg/kg bromodeoxyuridine 
(BrdU; Sigma, St. Louis, MO, USA) every 4 h for the subse-
quent 12 h (four administrations total). The animals were sac-
rificed 24 h (n=3), 48 h (n=3), 1 wk (n=7), 2 wk (n=5), and 3 wk 
(n=5) after the final BrdU “pulse” and processed for BrdU de-
tection. In some experiments designed to assess the long-term 
in vivo survival and permanence of BrdU-intercalated cells 
over months, daily “pulses” of BrdU for a week post-HI were 
performed. At the pre-determined timepoints for analysis, the 
animals were deeply anesthetized and perfused transcardially 
with 0.1 M PIPES buffer (pH 6.9; Sigma) containing 4% para-
formaldehyde. The brain was subsequently post-fixed in the 
perfusing solution overnight at 4°C, cryoprotected overnight 
in phosphate-buffered saline (PBS) containing 30% sucrose at 
4°C, and then embedded in O.C.T compound medium (Sakura 
Finetek, Torrance, CA, USA). Serial brain coronal cryostat sec-
tions (15-μm thick) were treated initially with 2N HCl for 30 
min at 37°C to denature cellular DNA and then reacted with a 
Fluorescein isothiocyanate (FITC)-conjugated mouse anti-
BrdU antibody and/or a mouse anti-BrdU antibody (Boeh-
ringer Mannheim, Indianapolis, IN, USA) followed by a bi-
otinylated-horse anti-mouse secondary antibody (Vector 
Laboratories, Burlingame, CA, USA), in order to identify Br-
dU-labeled cells.
Injection of retrovirus and detection
Retrovirus vector particles encoding lacZ were collected from 
the supernatants of confluent ψ2 BAG helper virus-free pack-
aging cells for 48 h at 37°C, filtered through 0.45 μm pores, ali-
quoted, and stored at -80°C.21 The BAG virus stock (8×107 G418-
resistant CFU/mL) was mixed with 8 μg/mL polybrene and 
trypan blue prior to gently expelling 2 μL through a finely 
drawn glass micropipette into each lateral ventricle of mice 2 h 
before the induction of HI. The brains were processed via 
standard methods described below and elsewhere for immu-
nohistochemisty.22 Expression of the lacZ gene product, E. coli 
β-galactosidase (βgal), was detected by rabbit anti-βgal anti-
body (1:1000; Cappel Laboratories, Cochranville, PA, USA) fol-
lowed by Texas red (TR)-conjugated goat anti-rabbit IgG (1:200; 
Vector Laboratories) antibodies. 
The pCLPIT GFP plasmid was used to produce the murine 
leukemia virus (MLV)-based retroviral vector expressing GFP.23 
The pCAG-NeuroD1-IRES-GFP sequence was subcloned from 
CAG-NeuroD1-IRES-GFP plasmid (Addgene, Watertown, MA, 
USA) and replaced the PuroR-IRES-tTA/TRE-GFP sequence in 
the pCLPIT GFP plasmid to generate the mouse NeuroD1/GFP-
expressing retroviral vector. Retrovirus vector particles encod-
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ing GFP or NeuroD1/GFP were collected from the superna-
tants of human embryonic kidney 293T cells and concentrated 
to about 108 TU/mL by ultracentrifugation.24 The virus stock 
solution was injected into each lateral ventricle of mice being 
subjected to HI, and the brains were processed as described 
above. The expressions of GFP and NeuroD1 gene products 
were detected by rabbit or mouse anti-GFP (1:100; Thermo Fish-
er Scientific, Waltham, MA, USA) and mouse anti-NeuroD1 
(1:500; Abcam, Cambridge, MA, USA) antibodies, respectively. 
Species-specific secondary antibodies, conjugated with FITC 
(1:200; Vector Laboratories) or TR (1:200; Vector Laborato-
ries), were used to detect the binding of primary antibodies.
Immunohistochemistry
Immunohistochemistry (IHC) analysis25 employed the anti-
BrdU, anti-βgal, anti-GFP, and/or anti-NeuroD1 antibodies de-
scribed above. Dual staining was performed with primary anti-
bodies against the following immature, undifferentiated NSPC 
and established differentiated neural cell type-specific anti-
gens: anti-NeuN (1:100; Chemicon, Billerica, MA, USA), anti-
neurofilament (NF) (1:500; Sternberger, San Diego, CA, USA), 
anti-Doublecortin (DCX) (1:50, Santa Cruz, CA, USA), anti-
Olig2 (1:200; Millipore, Billerica, MA, USA), anti-CNP’ase (1:500, 
Sternberger), anti-glial fibrillary acidic protein (GFAP) (1:1000; 
Dako, Glostrup, Denmark), anti-nestin (1:500; PharMingen, San 
Diego, CA, USA). Nuclear c-fos and synaptic connection with 
neighboring neurons were detected by a rabbit polyclonal anti-
c-fos (1:10000; Santa Cruz) and anti-synapsin 1 (1:500; Ther-
mo Fisher Scientific) antibodies, respectively. Species-specific 
secondary biotinylated (Vector Laboratories), streptavidin TR-
conjugated (1:200; Jackson, Cambridge, UK), FITC-conjugated, 
or TR-conjugated antibodies were used to detect the binding of 
primary antibodies. Specimens were mounted using the Vecta-
shield mounting medium with 4,6-diamino-2-phenylindole 
(DAPI; Vector Laboratories), and were analyzed by an immuno-
fluorescence microscopy (BX51; Olympus, Center Valley, PA, 
USA) or a confocal laser scanning microscopy (LSM 700; Carl 
Zeiss, Oberkochen, Germany).
Quantification
Structures were sampled by selecting predetermined areas on 
each coronal section as described.26 Every 6th section was se-
lected from a coronal series through the striatum between the 
following points relative to bregma: +0.98 mm (genu of the cor-
pus callosum) and +0.14 mm (anterior commissure crossing). 
Proliferating cells were ascertained by their BrdU incorporation, 
and their quantification was based on counts of BrdU-immuno-
reactive cells using the optical dissector stereological method.27 
BrdU+ cells were counted in three predetermined ventral, lat-
eral, and dorsal squares (50×50 μm) of the lateral ventricle wall 
on all selected sections. A rectangular area of the striatum (300× 
600 μm) was selected at a 50-μm distance from the lateral 
ventricle wall and analyzed on each section. All BrdU+ nuclei 
in these areas were counted. Every 12th section from a coro-
nal series [spanning from the olfactory bulb (OB) and frontal 
cortex rostrally and progressing caudally through the entire tel-
encephalon] was selected and processed for BrdU IHC. As de-
picted,26 four predetermined areas (50×50 μm) in the rostral 
migratory stream (RMS) and granule cell layer of the OB were 
analyzed on each section. All BrdU+ nuclei in these areas were 
counted.
Statistical analysis
All statistical analyses were performed using SPSS version 23 
(IBM Corp., Armonk, NY, USA). For statistical comparison of 
newly-born BrdU+ cell numbers, we performed two-way ANO-
VA to account for the effect of HI (non-injured vs. injured 
mice) and/or hemispheres (contralateral vs. ipsilateral hemi-
sphere). Bonferroni post hoc analysis was sequentially per-
formed for pairwise comparisons of groups at each time-
points where appropriate. Sample sizes were calculated using 
power analyses with an α-level of 0.05 and a power of 0.8. Data 
are presented as the means±SEM. p<0.05 was considered sta-
tistically significant.
RESULTS
Proliferation and migration patterns of BrdU-labeled 
endogenous NSPCs in response to unilateral HI
Following unilateral HI, the proliferation and migration pat-
terns of endogenous NSPCs in the periventricular regions of 
both hemispheres was assessed using the serial BrdU injec-
tion method. BrdU was selectively and permanently incorpo-
rated into the nuclear genomic material of all proliferating cells 
entering S-phase.10-14 HI induced a significantly increased pro-
liferation of BrdU-labeled V-SVZ NSPC population ipsilateral 
to the lesioned right side (Figs. 1 and 2). Furthermore, HI ap-
peared to induce a significant redistribution of proliferative 
NSPCs ipsilateral to the lesioned right side (Fig. 1B, D, F, and H) 
compared to the grossly intact contralateral left side (Fig. 1A, 
C, E, and G) and uninjured control group (n=5) (Fig. 2). The 
accumulation of BrdU+ cells was actually most pronounced in 
the dorsolateral wall of the lateral ventricles, particularly the 
anterior one-third of the V-SVZ (Fig. 1B, D, F, and H), adjacent 
to the infarction cavity (IC) (Fig. 1B, D, and F); and a relatively 
dense “stream” of newly-born cells (arrowhead in Fig. 1B) ori-
ented towards and into the extensively injured cortex was now 
apparent (arrows in Fig. 1B, D, F, H, and F’). The actual num-
ber of newly-born cells was, indeed, increased at the site of HI 
and its penumbra in the neocortex as well as in adjacent pa-
renchymal areas, particularly in the striatum (Fig. 1D, F, F’, 
and Fig. 2). About 2–4 times as many BrdU+ cells were seen in 
the ipsilateral cortex and striatum 24–48 h after BrdU pulse com-
pared to uninjured controls [e.g., cortex: 1964.2±246.5 (mean± 
SEM) vs. 495.6±78.8, p<0.05; striatum: 2950.8± 331.8 vs. 657.6± 
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78.5, p<0.05, respectively] (Fig. 2).
As the migratory route from V-SVZ to OB via the RMS is so 
well-characterized developmentally programmed destination 
of migratory V-SVZ NSPCs in the intact brain,6,8,9,28 examining 
it in the context of unilateral HI provides an ideal opportunity 
to assess the role HI might play in “shifting” migratory pat-
terns. The normal fate for most of the cells born in V-SVZ, par-
ticularly the anterior portion (“c-d” in the schematic in Fig. 1K 
and displayed in Fig. 1A-D), is to migrate rostrally along the 
RMS into the OB (“a-b” in the schematic in Fig. 1K and dis-
played in Fig. 1I and J), where they differentiate into the neu-
rons.8,9,28-30 Such typical developmental program is evident in 
the intact left hemisphere [e.g., few BrdU+ cells surrounding 
the left lateral ventricle (LV) in Fig. 1A and C; many BrdU+ cells 
in left OB (LOB) in Fig. 1I and J]. 
However, although more cells were actually born in the 
right V-SVZ ipsilateral to the lesion in response to HI (Fig. 1B 
and Fig. 2), significantly fewer BrdU+ cells (about 53% of unin-
jured controls) were present in the right RMS (Fig. 2) 1 wk after 
BrdU injection. In addition, the number of newly-born cells that 
actually reached the right OB (ROB) was reduced significantly 









a   b               c  d   e
OB SVZ
RMS
Fig. 1. Proliferation and migration patterns of BrdU-labeled endogenous NSPCs in response to unilateral HI. The schematic (K) shows the level of coronal 
section represented by each of following immunostained panels: the section through “a” is seen in (I); section through “b” is seen in (J); sections through 
“c” are seen in (A and B); sections through “d” are seen in (C and D); sections through “e” are seen in (E, F, and F’). The marked (*) areas in (E and F) are 
magnified in (G and H), respectively. The shaded region in (K) delineates the approximate area of injury in the right hemisphere [the side ipsilateral to (B, D, 
F, H, F’ and “ROB” in I and J)]. The normal fate of V-SVZ NSPCs is to migrate rostrally to the OB via the RMS. Accordingly, few of BrdU+ (green) V-SVZ 
NSPCs (particularly the anterior portion) on the intact left side (e.g., A and C) remain there; rather most have appropriately left the V-SVZ and migrated out 
rostrally to and become integrated in the LOB in (I and J). Strikingly, on the side ipsilateral to the injury on the right, BrdU+ cells in the V-SVZ [e.g., arrow-
head in (B)] appear to have been directed from migrating out rostrally to the ROB in (I and J) (where the number of BrdU+ cells is significantly diminished 
compare with adjacent LOB), but rather have remained near the injured brain in and around the V-SVZ and adjacent cortex and striatum. Arrows in (B, D, 
F, H, and F’) points to the extensive adjacent areas of degeneration emanating from the IC. HI induced increased accumulation of BrdU+ V-SVZ NSPCs ip-
silateral to the lesion (B, D, F, H, and F’) compared to the grossly intact contralateral side (A, C, E, and G) and to the non-injured control group (not shown, 
see Fig. 2). BrdU+ cells were more pronounced in the lateral [particularly dorsolateral anterior one-third, e.g., (B and D)] wall of the ventricles adjacent to 
and oriented (arrows) towards the IC. The density of BrdU+ cells entering the damaged cortex (epicenter of HI injury and its penumbra) appeared to be in-
creased [e.g., (B) compared to (A)]; there was also an increase in other adjacent areas: striatum [e.g., (D and F) compared to (C and E)] and cortex [e.g., 
(F’)]. Scale bars: 200 μm in (A and E); 100 μm in (G); 500 μm in (F’); 300 μm in (J). NSPCs, neural stem/progenitor cells; HI, hypoxic-ischemic brain injury; OB, 
olfactory bulb; ROB, right OB; RMS, rostral migratory stream; V-SVZ, ventricular-subventricular zone; LOV, left OB; IC, infarction cavity; LV, left lateral ven-
tricle; RV, right lateral ventricle.
496
Brain Injury Controls Stem Cell Movement and Fate
https://doi.org/10.3349/ymj.2020.61.6.492
tralateral to the lesion, e.g., ipsilateral ROB compared to contra-
lateral LOB in Fig. 1I, J, and Fig. 2), although the migration route 
remained anatomically intact. Interestingly, the number of 
newly-born cells that reached the RMS and OB from the V-SVZ 
contralateral to the lesion, though certainly much greater than 
that ipsilateral to the lesion, was also significantly reduced com-
pared to the uninjured control mice (Fig. 2). This suggested that 
injury may draw cells from even distant regions, affecting the 
migratory pattern of V-SVZ-derived cells even in the grossly in-
tact contralateral hemisphere. Indeed, the greater number of 
BrdU+ cells in the injured ipsilateral cortex contrasted with, and 
may also come at the expense of, about 76% fewer BrdU+ cells 
noted in the contralateral cortex compared to the age-matched 
uninjured controls (843.8±77.7 vs. 1117.0±121.9, p<0.05) (Fig. 2), 
suggesting that NSPCs which normally would have taken up 
residence in their contiguous cortex31 may be diverted to-
wards the lesion as the SVZ→RMS→OB axis was effected.
HI promotes the maintenance of cerebral nestin 
expression 
Consistent with the view that HI may have a broader effect 
throughout the brain was the pattern of cerebral nestin ex-
pression at various times—1 day (n=5), 1 wk (n=7), and 3 wk 
(n=5)—following unilateral HI, both at the site of injury and in 
the contralateral intact hemisphere. We analyzed the expres-
sion of an intermediate filament protein nestin via IHC, which 
is known as NSPC and radial glia (embryonic NSPC during 
CNS development) markers.32-34 In contrast to the restricted 
nestin-immunoreactivity (IR) bordering both lateral ventricles 
in the intact brain of age-matched control mice on P8 (Fig. 
3F), robust nestin-IR was evident not only in the periventricu-
lar regions of both lateral ventricles, but also in the septum, 
striatum, corpus callosum, external capsule, and cerebral cor-
tices of both hemispheres, particularly at the right cortical in-
farction site, 24 h after HI (Fig. 3A and B). In addition, the den-
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Fig. 2. Density of BrdU-positive newly-born cells following unilateral hypoxic-ischemic brain injury. BrdU+ cells of V-SVZ, RMS, OB, striatum, and cor-
tex in non-injured control and injured animal at 24 h (A), 48 h (B), and 1 week after the final BrdU pulse (C). The number of BrdU+ cells was not avail-
able to count at the cortex at 1 week after BrdU injection. Data represent the means±SEM. *p<0.05 vs. the corresponding regions in non-injured con-
trols, †p<0.05 vs. the contralateral side to the lesion in an injured animal. V-SVZ, ventricular-subventricular zone; RMS, rostral migratory stream; OB, 
olfactory bulb.
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be highly increased in both hemispheres (arrowheads in Fig. 
3A and B). The robust nestin-IR was maintained in HI site and 
cortical penumbral area of ipsilateral hemispheres 1 wk (Fig. 
3D) and even 3 wk (data not shown) after HI. However, the 
nestin-IR in the contralateral hemisphere decreased, except the 
external capsule, 1 wk after HI (Fig. 3C) and almost disap-
peared, except the dorsolateral SVZ adjacent to the LV, 3 wk af-
ter HI (Fig. 3E). These results suggest that neonatal HI promotes 
the maintenance of cerebral nestin expression and has the 
potential to maintain radial glia fibers after injury. 
The hypothesis that such appearance of nestin+ NSPCs or 
radial glia fibers (even in regions distant from the lesion) might 
reflect the rapid mobilization or recruitment of NSPCs to re-
gions of cell loss was supported by a further observation of 
BrdU+/nestin+ cells around both SVZs (Fig. 4A-C) and within 
both cortices (Fig. 4D-F). In addition, robust nestin-IR with 
A B
C D E F
JIHG
Fig. 3. Unilateral HI promoted the maintenance of cerebral nestin expression. Compared with restricted nestin (red) expression bordering the lateral 
ventricle in the intact brain of control mice on P8 (F), rapid and robust nestin expression was evident in the periventricular regions, septum, striatum, 
corpus callosum, external capsules (arrows in A and B), and cerebral cortices of both ipsilateral right (B) and contralateral left hemispheres (A), partic-
ularly at the right cortical infarction site (* in B), 1 day after HI. Density of nestin+ radial glia fibers with long processes appeared to be highly increased 
in both hemispheres (arrowheads in A and B). While nestin expression in the contralateral hemisphere decreased, except the external capsule (arrow 
in C), 1 week after HI and almost disappeared, except the dorsolateral SVZ adjacent the LV (the arrow in E), 3 weeks after HI, the robust nestin expres-
sion was maintained in HI site (arrowhead in D) and cortical penumbral area of the right hemispheres 1 week and even 3 weeks (data not shown) after 
HI. Many of the BrdU+ cells (arrows in G, dark brown) in the CC close to IHF showed migration towards HI-injured hemisphere analyzed 1 week after HI. 
Immunofluorescent labeling showed that migrating BrdU+ cells (arrow in I, green) in the CC bearing elongated leading processes towards affected 
hemisphere were dual-labeled with nestin (arrows in H and J, red). Scale bars: 500 μm in (A, C, E); 100 μm in (G). HI, hypoxic-ischemic brain injury; LV, 
left lateral ventricle; RV, right lateral ventricle; CC, corpus callosum; IHF, interhemisphere fissue; SVZ, subventricular zone.
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many BrdU+/nestin+ cells in the corpus callosum bearing elon-
gated leading processes oriented towards the affected hemi-
sphere suggested the migration of NSPCs in response to HI (Fig. 
3G-J). These findings suggest that nestin+ newly-born V-SVZ 
cells migrate towards adjacent parenchyma and HI site, and that 
retained nestin+ radial glia fibers in response to HI may provide 
a scaffold for the migration of V-SVZ-derived neurons and glia 
toward non-neurogenic brain regions in the postnatal brain.35
Differentiation pattern of BrdU-labeled NSPCs in 
response to HI 
To help determine the differentiation fate in vivo of HI-gener-
ated BrdU-labeled NSPCs, particularly in non-neurogenic re-
gions, they were analyzed for their co-expression of neural cell 
type-specific antigens (Figs. 4 and 5). Over the 3-week period 
following the final BrdU pulse, many of the cells were induced 
to proliferate yielded new oligodendrocytes [10.8% (mean), 
6.2%, and 7.4% at 1, 2, and 3 wk, respectively] (Fig. 4P-R and 
Fig. 5), astrocytes (28.3%, 15.6%, and 16.4%, respectively) (Fig. 
4S-U and Fig. 5), and neurons (4.0%, 1.2%, and 1.2%, respec-
tively; Fig. 4G-O and Fig. 5). These new neurons (likely an un-
der-representation given the time course of BrdU pulses) were 
evident not only in the compromised hemisphere, but in the 
contralateral hemisphere as well, suggesting the widespread 
“ripple effect” of signals emanating from even a unilateral le-
sion. In some experiments designed to assess even longer 
term survival of BrdU+ cells, daily ip BrdU pulses for a full week 
of post-HI were performed. At 2 months after injury, about 1% 
of BrdU+ cells were NF+—not significantly diminished from 




































Fig. 4. Differentiation pattern of BrdU-labeled NSPCs in response to HI. A day after unilateral HI and the final BrdU pulse, many cells around the V-
SVZ (A-C) and in the cortex (D-F) of both hemispheres showed co-localization of both anti-nestin (A, D) (red) and anti-BrdU (B, E) (green) immunoreac-
tivity (arrows), appreciated in merged images (C, F, respectively). One-to-three weeks after HI, many of the BrdU+ cells [arrows in (H, K, N, Q, T)] had dif-
ferentiated into new neurons (G-O), oligodendrocytes (P-R), and astrocytes (S-U) predominantly in the injured hemisphere, supplementing non-BrdU+ 
[arrowheads in (G, I, J, L, M, O, P, R, S, U)] of the respective cell type with which they seamlessly intermixed, and were often directly juxtaposed. The 
new neurons, recognized here as NF+ (red) cells [arrows in (G, J, M) and under the dual-wavelength filter in (I, L, O)], were present in the neocortex—
predominantly ipsilateral [arrows in (G-I)] but even contralateral to the lesion [arrows in (J-L)]—and in the ipsilateral hippocampal CA1 area [arrows in 
(M-O)]—all classically regarded as non-neurogenic regions. The oligodendrocyte marker CNP’ase and the astrocyte marker GFAP were employed in 
(P) [and under the dual filter in (R)] and (S) [and under the dual filter in (U)], respectively. Arrowheads in (A, C) indicate cellular processes of Nestin+/
BrdU- immature cells. Confocal images showed that a BrdU+ cell (green) (arrows) colocalized with the mature neuronal marker NeuN (red) under the 
dual-wavelength filter in (A’-N’). Scale bars: 10 μm in (A, D, H, K, M, A’); 5 μm in (Q, T). NSPCs, neural stem/progenitor cells; HI, hypoxic-ischemic brain 
injury; V-SVZ, ventricular-subventricular zone. 
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Fig. 5. Cellular differentiation patterns of HI-generated BrdU+ newly-born cells in non-neurogenic regions. Counts represent the means and SEM of 
the sums of every 6th 15-μm coronal section extending caudally from the rostral tip of the lateral ventricle for the entire expanse of both cerebral corti-
ces (ipsilateral and contralateral to HI). HI, hypoxic-ischemic brain injury.
rons. Notably, these analyses were performed caudal to the 
OBs and rostral to the dentate gyrus of hippocampus to prevent 
confusion with neurons routinely generated locally in these neu-
rogenic regions.5-14,16 Following HI, neurons are the neural cell 
type most susceptible to elimination, yet they are the very 
cells deemed as incapable of being renewed in non-neurogen-
ic regions. Given such expectations, the actual numbers were 
somewhat less consequential than the fact of observing any 
new neurons in areas that were heretofore regarded as harbor-
ing no new neurons, and were considered representative of 
most of the postnatal brain. The proportion of endogenous 
NSPCs differentiating into various neural cell types—including 
the proportion remaining immature and undifferentiated—was 
consistent with prior studies quantifying the phenotype of pro-
liferative cells following exogenous mitogen/growth factor infu-
sions.36-38
Tracking of LacZ-expressing V-SVZ NSPCs in response 
to HI
As a complement to BrdU labeling and to more rigorously 
track the fate of these newly proliferative HI-responsive V-SVZ 
NSPCs (as well as to selectively label periventricular cells inde-
pendent of local cortical parenchymal progenitors), mitotic 
cells were identified by their incorporation of a retroviral provi-
rus encoding lacZ following infection by a retrovirus vector21 
injected into the ventricles. A cell that was in S-phase at the 
time of exposure to the retrovirus indicated LacZ expression; 
therefore, LacZ expression, revealed by an antibody to βgal, 
provided a direct unambiguous tag for detecting, tracking, and 
determining the subsequent fate of that cell. The mice were 
sacrificed at least 1 wk after retrovirus injection into both later-
al ventricles of mice being subjected to unilateral HI (n=5) 
(Fig. 6). In response to HI, βgal+ V-SVZ cells migrated into the 
adjacent striatum (Fig. 6A) and hippocampus, into the cortex 
ipsilateral to the lesion (Fig. 6D), and into the cortical penum-
bra (Fig. 6J). In addition, some LacZ-labeled V-SVZ (often in 
groups29,30) also migrated into the cortex (Fig. 6G) and overlying 
hippocampal CA1 area (Fig. 6M). Providing a broader over-
view under low magnification, LacZ-labeled V-SVZ NSPCs fol-
lowing severe HI showed a robust radiating migratory pattern 
towards the overlying hippocampus and neocortex (Fig. 6P 
and Q). Confirming the observation noted in Fig. 6G-O, a sub-
population of the newly proliferative and migratory βgal+ cells 
now expressed mature neuronal marker (e.g., NeuN) in all of 
these non-neurogenic regions (Fig. 6C, F, I, L, O, and Q), sug-
gesting de novo neurogenesis. The NeuN+ neurons were sug-
gested to be active, integrated, and activatable in concert with 
other regional neurons, based on their immunohistochemically 
detectable upregulation and expression of c-fos and synapsin 
in the living, behaving animal (Fig. 6R-Z), e.g., in cortex includ-
ing the infarcted area (Fig. 6R-T, X-Z) and hippocampus (CA3) 
where 59.6±3.2% and 25.2±4.2% of LacZ+ cells were dual im-
munoreactive with NeuN and nestin, respectively (Fig. 6U-W). 
Tracking of NeuroD1/GFP-expressing V-SVZ NSPCs in 
response to HI
NeuroD1 is a basic helix-loop-helix (bHLH) transcriptional 
factor that is highly expressed in the developing neurons of pe-
ripheral and CNS, supporting its role as a neuronal differenti-
ation factor. NeuroD1 may contribute to multiple levels of 
neural development; nevertheless, it is believed that NeuroD1 
mainly plays important roles in the terminal differentiation of 
postmitotic neuronal cells.39 Therefore, we asked if NeuroD1-
transduced V-SVZ NSPCs could enhance neuronal differentia-
tion of internal pool of NSPCs and provide greater numbers of 
new neurons in non-neurogenic brain regions in response to 
HI. Retroviral vectors encoding NeuroD1/GFP and GFP were 
injected into both lateral ventricles of mice being subjected to 
unilateral HI (n=5 for each group) and analyzed at least 1–2 
wk later (Fig. 7). In response to HI, NeuroD1+/GFP+ mitotic V-
SVZ NSPCs migrated into the adjacent striatum, subcortex, 
and cortical penumbra ipsilateral to the lesion (Fig. 7A, A’, B, B’), 
and along the external capsule and corpus callosum (Fig. 7A, 
A”, and B). The majority of newly-born and migratory GFP+ 
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Fig. 6. Immunostaining of retrovirally-infected endogenous mitotic V-SVZ NSPCs with LacZ following HI. In response to HI, LacZ-expressing βgal+ 
cells (red) migrated widely, including into the striatum (A), the cortex ipsilateral to the lesion (D), and the cortical penumbra of the infarct (J). Some of 
these βgal+ cells (A, D, J) (red, arrows) expressed the mature neuronal marker NeuN (B, E, K, respectively) (green, arrows) with co-localization of 
both antibodies visualized under a dual filter (C, F, L, respectively) (arrows), suggesting de novo neurogenesis. Arrowheads in (B, C) indicate neurons 
that were not the progeny of retrovirus-infected NSPCs. In the grossly intact contralateral hemisphere, there was also evidence for the migration and 
differentiation into NeuN+ neurons of some βgal+ cells in the neocortex (G-I) (arrows) and hippocampal CA1 region (M-O) (arrows) in response to se-
vere HI. These phenomena were further illustrated by a low magnification view of the cerebral cortex and hippocampus, in which a significant num-
ber of βgal+ V-SVZ NSPCs that migrated to these regions (P) (red) differentiated into NeuN+ neurons (Q) (yellow/orange under a dual filter). Insets in (P) 
and (Q) showed the representative βgal+ cell indicated by the arrow in (P) and (Q), respectively, further enlarged to illustrate the typical morphology of a 
newly-born neuron derived from a labeled V-SVZ cell that had migrated to the neocortex following injury. (R-Z) The representative βgal+ cells in those 
regions [red cells with arrows in (R) and (U, X)] were immunoreactive to an anti-synapsin 1 [green cell with the arrow in (S)] and c-fos nuclear [green 
cells with arrows in (V, Y)] antibodies, respectively, and visualized under a dual filter [cells with arrows in (T, W, Z)]. Scale bars: 50 μm in A; 5 μm in D, G, 
J; 10 μm in M, R, U, X; 100 μm in P. V-SVZ, ventricular-subventricular zone; NSPCs, neural stem/progenitor cells; HI, hypoxic-ischemic brain injury. 
cells transduced with a retrovirus encoding GFP expressed as-
trocyte marker GFAP (65.1±5.6%) (Fig. 7C-E”) and the oligo-
dendroglial progenitor marker Olig2 (22.4±3.8%) (Fig. 7F-H’), 
whereas relatively few expressed early neuronal marker DCX 
(11.3±2.5%) in the striatum and cortical penumbral area (Fig. 
7I-K’). In contrast, most of the newly-born and migratory GFP+ 
cells transduced with a retrovirus encoding NeuroD1/GFP did 
not express GFAP or Olig2, but expressed early neuronal mark-
er DCX or mature neuronal marker NeuN (95.1±7.4%) in all of 
these non-neurogenic brain regions (Fig. 7L-X), suggesting 
enhanced neurogenesis. In addition, very few of GFP+ cells 
(1.3±0.7%) expressed nestin (data not shown).  
DISCUSSION
This study sought to elucidate the brain’s intrinsic response to 
HI, particularly as it involves an endogenous V-SVZ NSPC pool 
and specifically in areas that are designated "non-neurogenic" 
and hence non-regenerative. Our findings suggest that neo-
natal HI alters developmental programs and does so towards 
the goal of repopulation and self-repair, allocating new cells to 
the regions of greatest need; during acute phases of neurode-
generation, many factors, such as morphogens, growth factors, 
neurotrophic factors, erythropoietin, and microRNAs, are elab-
orated to which endogenous NSPCs may respond to promote 
the establishment of new neurons, even within non-neuro-
genic regions of the postnatal brain.17,40 Some of these newly-
born neurons, while generated from V-SVZ NSPCs, appear to 
be targeted specifically to damaged, neuron-deficient regions 
by redirecting otherwise stereotypical migratory patterns. 
Such observations may attest to an under-appreciated degree 
of plasticity and resilience in the mammalian CNS, even be-
yond the classical periods and regions of developmental malle-
ability. The CNS may, indeed, spontaneously attempt to repair 
itself with its own endogenous pool of NSPCs, but that supply 
may simply be insufficient either in number or in factors regu-
lating proliferation, migration, and differentiation in the con-
text of the most destructive injuries. Therefore, the net impact 
of the production of new nerve cells may be limited. It is plau-
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sible that this type of homeostatic response occurs routinely 
at a marginally detectable level, and is effective under most 
circumstances (where CNS insults are modest—e.g., from in-
fections, toxins, minor trauma) in preventing such events from 
coming to clinical attention. However, when the damage is mas-
sive, the system—invoked but inadequate—is “overwhelmed.” 
Consequently, there is no apparent recovery, although endog-
enous NSPCs have responded in a “reparative” fashion to sig-
nals directing them towards repopulation of the damaged area. 
Nevertheless, this does not negate the inherent plasticity of CNS 
nor the potential for augmenting this response. Therefore, the 





































Fig. 7. Immunostaining of retrovirally-infected endogenous mitotic V-SVZ NSPCs with NeuroD1/GFP and GFP following HI. In response to HI, Neu-
roD1/GFP-expressing GFP+ cells (green) migrated into the adjacent striatum, subcortex, and cortical penumbra ipsilateral to the lesion (A, A’, B, B’), 
and along the EC and CC (A, A”, B). The boxed areas in A and B are shown at high magnification in A’, A” and B’. The asterisk in A’ and arrowheads in 
A” indicates the infarction cavity and LV, respectively (C-K’). Many of the newly-born and migratory GFP+ cells (C, C’) transduced with a retrovirus en-
coding GFP expressed astrocyte marker GFAP (D, D’, respectively) (red) with co-localization of both antibodies visualized under a dual filter (E, E’, re-
spectively) (yellow or orange) in the cortical penumbral area. Boxed regions in (C-E) are magnified in (C’-E’), respectively. Arrows in (C’-E”) indicate dual-
labeled cells (F-H). Some of newly-born GFP+ cells (F) expressed the oligodendrocyte progenitor marker Olig2 (G) (red) with co-localization of both 
antibodies visualized under a dual filter (H). Arrows in (F-H) indicate dual-labeled cells. (I-K) A few of newly-born GFP+ cells (I) expressed early neuronal 
marker DCX (J) (red) with co-localization of both antibodies visualized under a dual filter (K). Confocal images showed that GFP+ cells (arrows in E”, H’ and 
K’) colocalized with differentiation markers under a dual filter (yellow or orange) (L-X). In contrast, most of the newly-born and migratory GFP+ cells [ar-
rows and arrowheads in (R) and (U), respectively] transduced with a retrovirus encoding NeuroD1/GFP expressed early neuronal marker DCX [arrows 
in (S)] (red) or mature neuronal marker NeuN [arrowheads in (V)] (red) with co-localization of both antibodies visualized under a dual filter [arrows in (T)] 
(yellow or orange) in the striatum and cortical penumbral area. DAPI+ cells [arrowheads in (W)] (blue) indicate dual-labeled cells. Confocal images 
showed that GFP+ cells [arrows and arrowheads in (T’) and (X), respectively] colocalized with neuronal markers under a dual filter (yellow or orange). 
However, GFP+ cells (L, O) did not express GFAP or Olig2 (M, N, P, Q). Scale bars: 500 μm in (A); 20 μm in (H’, N) 10 μm in (A”, E, E”, H). V-SVZ, ventricular-
subventricular zone; NSPCs, neural stem/progenitor cells; HI, hypoxic-ischemic brain injury; EC, external capsule; CC, corpus callosum; LV, left lateral 
ventricle; RV, right lateral ventricle.
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mains to be explored. The prediction of NSPC response based 
on the level of severity of HI is an important issue that should 
be further investigated.
While it is clear that newly-born brain cells are being pro-
duced in response to HI, data compiled to date suggest that the 
long-term survival of migrated neuroblasts or newly-born neu-
rons in the injured area is not supported.41-43 The reasons for the 
death of newly-born neurons remain elusive and may be due 
to the inhospitable post-HI environment. HI initiates an inflam-
matory cascade, such as microglial activation, immune cells in-
filtration, and the release of toxic proinflammatory molecules.44 
Microglial activation, proinflammatory factors, and circulating 
monocytes associated with inflammation not only lead to neu-
ron death but also affect the neurogenesis and survival of new-
ly-born neurons.40 In addition, some studies have indicated that 
SVZ-derived migratory NSPCs differentiate into reactive astro-
cytes and contribute to astrocyte scar formation after stroke.45,46 
While the role of astrogliosis after stroke or HI is still elusive and 
requires further investigation, the modulation of pathologic en-
vironment after HI by anti-inflammatory or neurogenic factors 
results in substantial repair of neural tissue.47,48 
Radial glial (RG) cells are embryonic neural stem cells express-
ing nestin, GFAP, and astrocyte-specific glutamate transporter 
that extend apical long processes to the pial surface from their 
soma, which is located in the ventricular zone.33 RG cells are 
not only stem cells and progenitors, but during brain develop-
ment they also provide a scaffold along which newly generated 
immature neurons migrate from the periventricular zone into 
the neocortex and to subcortical structures. In the late fetal pe-
riod in the human brain, and in the first postnatal week in the 
rodent brain, the RG fibers collapse, transform into astrocytes 
or ependymal cells, and normally disappear soon after birth.49 
However, this study showed that signals generated in HI elic-
ited robust cerebral nestin expression, and the density of nes-
tin+ radial glia fibers with long processes appeared to be highly 
increased in both hemispheres. Moreover, the robust nestin-
IR was maintained in the lesioned and cortical penumbral ar-
eas of ipsilateral hemispheres, even more than 3 weeks after 
HI. These findings suggest that retained nestin+ radial glia fi-
bers in response to HI may provide a scaffold for the wide-
spread migration of V-SVZ-derived neurons toward non-neu-
rogenic brain regions in the postnatal brain. Similarly, earlier 
studies reported an increase in cells expressing RG markers 
after chronic hypoxia in immature rats, and demonstrated the 
role of RG cells in both neurogenesis and migration.50,51 A recent 
study also showed that RG fiber persisted in neonatal mouse 
brain after cryogenic injury and acted as a scaffold for the mi-
gration of V-SVZ-derived neuroblasts to the lesion site, thereby 
enhancing neuronal regeneration and functional recovery from 
neonatal brain injuries.35
Whereas there has been a great increase of studies observ-
ing neuronal replacement after neonatal HI, there have been 
fewer studies assessing the extent of oligodendroglial replace-
ment. This study, along with other reports,52-54 documented an 
increase in the number of newly generated oligodendrocytes 
in the damaged hemispheres and suggested that these newly-
born oligodendrocytes were produced by V-SVZ NSPCs. How-
ever, none of these studies clearly established whether these 
newly-born oligodendrocytes proceeded to differentiate into 
mature myelin-producing cells. In this study, significant astro-
gliosis was observed after HI, along with an increase in BrdU+/
GFAP+ cells. It is well-known that reactive astrocytes produce 
extracellular matrix components, such as hyaluronic acid and 
chondroitin sulfate proteoglycan, that inhibit oligodendrocyte 
differentiation.55,56 In addition, astrocytes produce numerous 
cytokines, including fibroblast growth factors, WNT ligands, 
endothelin-1, and Notch ligands, that inhibit oligodendrocyte 
progenitor cell maturation.17 There is also an alternative expla-
nation for the lack of myelination depending on SVZ cell speci-
fication.57,58 However, further research is critically needed to fa-
cilitate the differentiation into mature, myelin-producing cells 
from V-SVZ NSPC-derived oligodendrocytes in HI.
Identifying the cues that promote the movement and differ-
entiation of this endogenous pool of NSPCs during their nor-
mal, developmentally-appropriate migratory course28-30,59,60 
and, as we observed here, during their confrontation with neu-
rodegeneration, may allow those factors to be provided thera-
peutically at even more optimal, sustained levels, over broader 
periods and terrain. In fact, multiple cytokines, such as Delta/
Notch-1, erythropoietin, interleukin-6, leukemia inhibitory 
factors (LIF), transforming growth factor, and vascular endo-
thelial growth factor (VEGF), were reported to be elaborated 
to which endogenous NSPCs respond to change in their pro-
liferation, migration, and differentiation patterns after neona-
tal HI. In addition, the treatment of erythropoietin, brain-de-
rived neurotrophic factor, epidermal growth factor, VEGF, LIF, 
hyperbaric oxygen, or hypothermia has been shown to atten-
uate HI by modulating the behavior of endogenous NSPCs.17,40 
Lastly, we have demonstrated here that neurogenic transcrip-
tional factor NeuroD1 can efficiently convert V-SNZ NSPCs to 
neurons, providing a new target for cellular conversion strate-
gies aimed at enhancing neurogenesis. Therefore, augment-
ing the endogenous NSPC population with exogenous neural 
stem cells,40 factors, and/or providing adequate synaptic neigh-
bors and guidance cues for connectivity and trophic support 
may enable more significant recovery. 
 BrdU labeling for mitotic cells is still the most commonly 
used of the thymidine analogues, and much work on this sub-
ject has been done in mice. However, BrdU inhibited the ex-
pansion of NSPCs, increased cell death, and repressed neuro-
nal and oligodendroglial differentiation.61 Although BrdU 
does obviously label dividing cells, BrdU positivity may be due 
to attempts of cells to repair themselves or a sign of cell death 
(apoptosis). In addition, BrdU has been well-known to have 
detrimental effects on chromosomes and DNA stability, as well 
as the cell cycle, cell differentiation, and survival.62 Besides the 
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toxicity of BrdU and caveats concerning its utility, BrdU label-
ing, particularly at the epicenter of HI, can be hard to interpret 
due to the reliance on immunodetection in the injury setting, 
where significant labeling issues can arise. In addition, BrdU 
is subject to dilution effects, where the absence of labeling or 
decreased labeling over time can be misinterpreted. There-
fore, we also utilized a retroviral vector to label mitotic NSPCs 
and their progeny, a technique that is not affected by the num-
ber of cell divisions. Another advantage of using a retroviral 
approach is the ability to direct the location of injection into V-
SVZ NSPCs. Gene transfer mediated by replication-incompe-
tent retroviral vectors has played an important role in develop-
mental studies, particularly in revealing lineage relationships 
among different cell types. Replication-incompetent retroviral 
vectors have also been used for gain-of-function studies to ex-
plore the molecular mechanisms underlying cell differentia-
tion in neural tissues of mice. The greatest advantage of this 
approach is that it can reveal cell-autonomous effects of a 
transgene, such as NeuroD1, on cell differentiation without dis-
rupting the overall context of development.63 However, gam-
ma retroviral vectors have a propensity to integrate near regula-
tory regions of active genes. The activity of promoter/enhancer 
elements within the vector long terminal repeats (LTRs) or ab-
errant splicing events can lead to the activation of genes flank-
ing the integration site. This is commonly referred to as inser-
tional mutagenesis. If the genes near the integration sites are 
proto-oncogenes, it may lead to increased proliferation of clonal 
populations of cells. In addition, a number of studies have shown 
that the promoter regions of gamma retroviral vectors may be 
subject to epigenetic silencing, which has been associated with 
DNA methylation of CpG sequences. Such silencing events 
gradually reduce the expression of transgenes, such as LacZ, 
GFP, or NeuroD1, under the control of both viral LTR and in-
ternal promoters.64 Taken together, it is difficult to find a single 
method to accurately and dynamically track the behaviors of 
endogenous NSPCs in response to HI. Therefore, more sophis-
ticated measures including the use of genetic mouse models 
or live molecular imaging would be required to avoid the com-
mon mistake of demonstrating the behaviors of endogenous 
NSPCs in HI. 
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